Replies to post #385010 on Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

The story of Brilacidin against new and old virus is not complete.
*The Company is also pleased to report Brilacidin has been shipped to two academic laboratories for planned in vitro testing of Brilacidin in over 20 acutely infectious viruses, including Ebola, Marburg, Nipah, West Nile and Zika, through a collaboration with U.S. government scientists. The goal of this testing is to further inform the spectrum of Brilacidin’s antiviral properties.*

But sure we will need money to read more of the story.